HAylation of Tranexamic acid microneedling in melasma: A controlled comparative split-face trial

Background Melasma is a common, challenging hyperpigmentation causing a significant negative impact on quality of life. Tranexamic acid (TXA) showed optimistic results, however, optimization of administration protocol is required to enhance and sustain therapeutic outcomes. Objective This trial evaluated the additive effect of hyaluronic acid (HA) when combined with TXA microneedling in melasma. Methods This split-face trial included 27 patients with bilateral melasma. Disease severity was assessed by hemi-modified Melasma Area and Severity Index (hmMASI) and dermoscopic examination. The right side of the face received TXA (100mg/ml) via microneedling, while the left side received HA 3.5% co-administered with TXA microneedling. Sessions were held once every two weeks for six sessions. Results Both treatment protocols showed significant reduction in hmMASI and dermoscopy (P<0.001 and P=0.01 respectively). The HA-TXA treated side demonstrated significantly higher improvement than TXA alone (P=0.003) with significantly higher percentage of excellent responders 66.7% versus 18.5% respectively (P<0.001). The TXA treated side showed resurgence of melasma (P=0.005), while the therapeutic response was sustained on the HA-TXA treated side (P=1). Additionally, the vascularity improvement was significantly higher on the hyaluronic-tranexamic acid treated side (P=0.012). Conclusions The co-administration of hyaluronic acid with tranexamic acid microneedling in melasma patients increases treatment efficacy, sustains its effects and reduces downtime and side effects.

Authors

Institutions

Publication Details

Journal
Clinical and Experimental Dermatology
Published
2026-11-21
DOI
https://doi.org/10.1093/ced/llag485
Primary Topic
Dermatologic Treatments and Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

HAylation of Tranexamic acid microneedling in melasma: A controlled comparative split-face trial

Hagar O. Nofal, Nourhan Anis, Enayat Mohamed Atwa, Omnia Tarabya
Clinical and Experimental Dermatology
Dermatologic Treatments and Research
article

HAylation of Tranexamic acid microneedling in melasma: A controlled comparative split-face trial

Hagar O. Nofal, Nourhan Anis, Enayat Mohamed Atwa, Omnia Tarabya
article en

Abstract

Background Melasma is a common, challenging hyperpigmentation causing a significant negative impact on quality of life. Tranexamic acid (TXA) showed optimistic results, however, optimization of administration protocol is required to enhance and sustain therapeutic outcomes. Objective This trial evaluated the additive effect of hyaluronic acid (HA) when combined with TXA microneedling in melasma. Methods This split-face trial included 27 patients with bilateral melasma. Disease severity was assessed by hemi-modified Melasma Area and Severity Index (hmMASI) and dermoscopic examination. The right side of the face received TXA (100mg/ml) via microneedling, while the left side received HA 3.5% co-administered with TXA microneedling. Sessions were held once every two weeks for six sessions. Results Both treatment protocols showed significant reduction in hmMASI and dermoscopy (P<0.001 and P=0.01 respectively). The HA-TXA treated side demonstrated significantly higher improvement than TXA alone (P=0.003) with significantly higher percentage of excellent responders 66.7% versus 18.5% respectively (P<0.001). The TXA treated side showed resurgence of melasma (P=0.005), while the therapeutic response was sustained on the HA-TXA treated side (P=1). Additionally, the vascularity improvement was significantly higher on the hyaluronic-tranexamic acid treated side (P=0.012). Conclusions The co-administration of hyaluronic acid with tranexamic acid microneedling in melasma patients increases treatment efficacy, sustains its effects and reduces downtime and side effects.

Clinical and Experimental Dermatology
Zagazig University (EG), American University in Cairo (EG)
Dermatologic Treatments and Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
HAylation of Tranexamic acid microneedling in melasma: A controlled comparative split-face trial — Hagar O. Nofal, Nourhan Anis, et al. · Clinical and Experimental Dermatology (2026) | TGRS Research Map | TGRS